OBX Obsidian Therapeutics, Inc.: institutional ownership and insider trading
1 funds reported holding $14 of Obsidian Therapeutics, Inc. in their latest 13F filings; over the last 12 months insiders bought $0 and sold $0 on the open market.
Largest institutional holders of OBX
- SBI Securities Co., Ltd. — $14
5%+ owners
- RA Capital Management, L.P.: 9.7% (Schedule 13G, filed Aug 10, 2026)
- Paradigm BioCapital Advisors LP: 6.6% (Schedule 13G, filed Oct 5, 2026)
- Deep Track Capital, LP: 5.4% (Schedule 13G, filed Aug 11, 2026)
- Novo Holdings A/S: 5.1% (Schedule 13G, filed Aug 10, 2026)